CClinicalTrials.gg
CompletedNCT06145386Updated Jan 24, 2025

"The Effect of Aerobic Exercise and Strength Training on Physical Activity Level, Quality of Life and Anxiety-Stress Disorder in Young Adults With and Without Covid-19"

An interventional study of Aerobic Exercise and Strength Training in COVID-19, sponsored by Pamukkale University. Completed at 1 site in Turkey. Open to participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-01-24.

Sponsored by Pamukkale University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 1 year 9 months after the study started (first participant enrolled Feb 2022, registered Nov 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Non-randomized
Ages
18 Years to 25 Years
Sex
All
01

Study summary

The purpose of this study; to examine the effects of aerobic and strength training on physical activity level, quality of life and anxiety-stress disorder in young adults with and without COVID-19. In this context, the study was planned by including 15 participants between the ages of 18-25 who had COVID-19 and 15 who did not have COVID-19. Data were collected by applying the Personal Data Form, IPAQ (International Physical Activity Form), SF-36 Quality of Life Scale, Coronavirus Anxiety Scale (CCS), Respiratory Function Tests (PFT), Six Minute Walk Test (6MWT). Aerobic training and strengthening training were applied to people with and without COVID-19 for 12 weeks. Aerobic exercise (walking) was given for 40 minutes 5 days a week, with the target heart rate being 70% of the age-corrected maximum heart rate. Strengthening exercises were applied to the upper (triceps, biceps, deltoid, pectorals) and lower (quadriceps, hamstring, gastrocnemius, tibialis anterior, hip adductors, hip flexors, hip extensors) extremities and back muscles (trapezius, latissimus dorsi) with theraband (resistance band). Significance test of the difference between two means in comparing independent group differences when parametric test assumptions are met for statistical analysis in line with the data collected from the participants; When parametric test assumptions are not met, Mann Whitney U test is used to compare independent group differences, while when parametric test assumptions are met to examine dependent group differences, the significance test of the difference between the two spouses is used; When parametric test assumptions were not met, the Wilcoxon paired two sample test was used. In all analyses, p \< .05 was considered statistically significant.

02

Conditions studied

  • COVID-19

Browse trials for

Keywords

  • aerobic exercise, strength training, pulmonary capacity
03

In context

COVID-19

7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's enrollment of 30 is below the median of 100 across 4,099 interventional studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

Pamukkale University is the lead sponsor of 331 studies on the registry; 61 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Volunteering to participate in the study,
  • Able to communicate, without hearing and/or visual impairment,
  • Being between the ages of 18-25
  • Not having a systemic disease
  • Having had COVID-19 in the last 6 months to be included in the study group

Exclusion criteria

Exclusion Criteria:

  • Unable to communicate, hearing and/or visually impaired,
  • Not being between the ages of 18-25
  • Having a systemic disease other than COVID-19 infection,
  • Having had COVID-19 more than 6 months ago.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    COVID-19 positive

    Behavioral: Aerobic Exercise and Strength Training

  • Experimental
    COVID-19 negative

    Behavioral: Aerobic Exercise and Strength Training

Interventions

  • BehavioralAerobic Exercise and Strength Training

    Aerobic Exercise and Strength Training on Physical Activity Level, Quality of Life and Anxiety-Stress Disorder in Young Adults With and Without Covid-19

06

What researchers measure

Primary outcomes

  1. International Physical Activity Questionnaire

    Used to define participants physical activity level

    Time frame: 5 minute

  2. SF-36

    Used to indicate the health status of participants

    Time frame: 10 minute

  3. Coronavirus Anxiety Scale

    Used to evaluate experience some psychological problems such as anxiety and depression depends on COVID-19

    Time frame: 1 minute

  4. Respiratory Function Tests

    Used to evaluation of the respiratory system

    Time frame: 5 minute

  5. The 6 Minute Walk Test

    Used to assess aerobic capacity and endurance

    Time frame: 6 minute

07

Study locations

1 site
  • Istanbul Aydin University
    Istanbul, Kücükcekmece, Turkey
08

References and documents

Individual participant data

Plan to share: No — If there is a reasonable request.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06145386
Lead sponsor
Pamukkale University
Responsible party
Ozge Mine Yilmaz (PhD Student, Pamukkale University) — Principal investigator
First posted
Nov 24, 2023
Start date
Feb 21, 2022
Primary completion
Apr 21, 2023
Completion
Dec 19, 2024
Last update
Jan 24, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion